FIGURE

Fig. 4.

ID
ZDB-FIG-211202-4
Publication
Kaveh et al., 2021 - Selective CDK9 inhibition resolves neutrophilic inflammation and enhances cardiac regeneration in larval zebrafish
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4.

AT7519 is a more selective CDK9 inhibitor than FVP in zebrafish. (A) Brightfield images of a cdk9+/+ (top), cdk9+/− (middle) and cdk9−/− (bottom) whole zebrafish at 4 dpf. Scale bars: 1 mm. (B) Restriction enzyme digest gel displaying cdk9 genotypes of zebrafish larvae. Hyperladder (HL) band and individual genotype bands (in order: cdk9−/−, cdk9+/− and cdk9+/+) are indicated. (C,E) Heart rate (beats/min) (C) and percentage survival (E) of cdk9−/− larvae at 2 hpt, 6 hpt, 12 hpt, 24 hpt and 48 hpt with 0.1%, DMSO vehicle, 1 μM AT7519 or 1 μM FVP treatment. (D,F) Heart rate (beats/min) (D) and percentage survival (F) of cdk9−/− larvae at 2 hpt, 6 hpt, 12 hpt, 24 hpt and 48 hpt with 0.3% DMSO vehicle, 50 μM AT7519 or 3 μM FVP treatment. (C,D) Error bars represent s.e.m., n=15 larvae, experimental n=3. **P<0.01, ***P<0.001, ****P<0.0001 (two-way ANOVA and Bonferroni post-hoc test for comparisons between DMSO vehicle or CDK9i treatment groups).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development